0001193805-24-000827.txt : 20240618 0001193805-24-000827.hdr.sgml : 20240618 20240618210059 ACCESSION NUMBER: 0001193805-24-000827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Markels John CENTRAL INDEX KEY: 0001803424 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38942 FILM NUMBER: 241053777 MAIL ADDRESS: STREET 1: C/O SANGAMO THERAPEUTICS, INC. STREET 2: POINT RICHMOND TECH CTR, 501 CANAL BLVD. CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001768224 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8589002660 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 e663728_4-markels.xml X0508 4 2024-06-14 0 0001768224 Arcturus Therapeutics Holdings Inc. ARCT 0001803424 Markels John C/O ARCTURUS THERAPEUTICS HOLDINGS INC. 10628 SCIENCE CENTER DRIVE, SUITE 250 SAN DIEGO CA 92121 1 0 0 0 0 Common Stock 2024-06-14 4 M 0 3131 0.00 A 3131 D Deferred Stock Units 0.00 2024-06-14 4 M 0 3131 0.00 D Common Stock 3131 0 D Stock option (right to buy) 31.00 2024-06-14 4 A 0 15000 0.00 A 2034-06-14 Common Stock 15000 15000 D Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024. Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. /s/ Ilan Katz, attorney-in-fact 2024-06-18